PRCT vs. PSEC

In the year-to-date period, PRCT achieves a -29.66% return, which is significantly lower than PSEC's -15.90% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PRCT Sharpe Ratio is -0.27, which is higher than the PSEC Sharpe Ratio of -1.05. The chart below compares the historical Sharpe Ratios of PRCT and PSEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PRCT has not paid dividends to shareholders, while PSEC's dividend yield for the trailing twelve months is around 18.16%.

The maximum PRCT drawdown since its inception was -63.51%, roughly equal to the maximum PSEC drawdown of -61.51%. Use the drawdown chart below to compare losses from any high point for PRCT and PSEC. For additional features, visit the drawdowns tool.

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 16.02% compared to Prospect Capital Corporation (PSEC) at 8.50%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than PSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Prospect Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.